David Ghez

Villejuif, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Cerebral aspergillosis under ibrutinib therapy: clinical features and management challenges.

Cerebral aspergillosis under ibrutinib therapy: clinical features and management challenges.

Journal: The Journal of antimicrobial chemotherapy

Published: March 08, 2026

SWI/SNF alterations define a subgroup with poorer outcome among patients with aggressive forms of adult T-cell leukemia/lymphoma.

SWI/SNF alterations define a subgroup with poorer outcome among patients with aggressive forms of adult T-cell leukemia/lymphoma.

Journal: Haematologica

Published: February 13, 2026

Waldenström's macroglobulinemia: The LYSA pragmatic guidelines.

Waldenström's macroglobulinemia: The LYSA pragmatic guidelines.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 28, 2025

Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real-World Analysis.

Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real-World Analysis.

Journal: EJHaem

Published: November 28, 2024

Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm.

Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm.

Journal: Blood advances

Published: August 20, 2024

The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.

The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.

Journal: Frontiers in immunology

Published: July 31, 2023

Crystal-storing lymphocytosis.

Crystal-storing lymphocytosis.

Journal: American journal of hematology

Published: April 17, 2023

Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation.

Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation.

Journal: Immunotherapy

Published: March 23, 2023

Incidence, characteristics, management and outcome of patients with follicular lymphoma with tumor epidural compression, a study on 22 cases.

Incidence, characteristics, management and outcome of patients with follicular lymphoma with tumor epidural compression, a study on 22 cases.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: February 13, 2023

Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients.

Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients.

Journal: Haematologica

Published: December 16, 2022

Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study).

Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study).

Journal: Haematologica

Published: September 26, 2022

Acalabrutinib in Membranous Nephropathy Associated With Chronic Lymphocytic Leukemia.

Acalabrutinib in Membranous Nephropathy Associated With Chronic Lymphocytic Leukemia.

Journal: Kidney international reports

Published: September 01, 2022

Showing 1-12 of 63

Last Updated: 09/26/2026